lipoma preferred partner (lpp) regulates breast cancer cell migration and invasion
Published 3 years ago • 332 plays • Length 52:17Download video MP4
Download video MP3
Similar videos
-
1:00:52
nicholas kurniawan - understanding cancer - cell–matrix interactions and the 3d cell migration
-
1:52
what are checkpoint inhibitors
-
1:19
what is the prognosis and predictive information for lymph node negative patients?
-
1:45
cell membrane ruffles disrupt growth factor signaling in the hep3b liver cancer cell line
-
1:37
dr. ready on the benefit of pd-l1 inhibition in sclc
-
2:40
pola-g-len for r/r follicular lymphoma
-
2:10
use of preoperative fdg pet/ct and survival of patients with resectable non–small cell lung cancer
-
8:46
atypical lipomatous tumor
-
1:59
answers from the experts: long term expectations with alcl
-
1:04
john p. leonard, md discusses lenalidomide plus rituximab for the treatment of mcl
-
0:25
dr. opyrchal: if a patient’s tumor is er /pr , how does that impact your treatment decisions?
-
6:59
case 2: diagnosing pd-l1 and egfr lung adenocarcinoma
-
2:41
rb/rc induction for mantle cell lymphoma: promising pooled analysis data
-
0:57
what are lipomas or multiple lipomas? can lipoma turn cancerous?
-
2:52
can we offer a curative treatment to transplant-ineligible r/r dlbcl patients?
-
1:23
new cancer technology developed by npl
-
25:58
cells, gene programs, and spatially organized immune hubs in mmrd and mmrp colorectal cancer
-
1:43
lipoma arborescens of shoulder
-
0:39
daniel petrylak, md, on the current role of ctc tumor cell components via liquid biopsy pc treatment